Free Trial
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

RadNet logo
$55.26 -0.94 (-1.67%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$57.08 +1.82 (+3.29%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About RadNet Stock (NASDAQ:RDNT)

Key Stats

Today's Range
$55.24
$57.49
50-Day Range
$52.07
$61.14
52-Week Range
$45.00
$93.65
Volume
413,840 shs
Average Volume
680,462 shs
Market Capitalization
$4.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.60
Consensus Rating
Strong Buy

Company Overview

RadNet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

RDNT MarketRank™: 

RadNet scored higher than 84% of companies evaluated by MarketBeat, and ranked 259th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    RadNet has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    RadNet has only been the subject of 2 research reports in the past 90 days.

  • Read more about RadNet's stock forecast and price target.
  • Earnings Growth

    Earnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of RadNet is -128.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of RadNet is -128.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    RadNet has a P/B Ratio of 3.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about RadNet's valuation and earnings.
  • Percentage of Shares Shorted

    9.35% of the float of RadNet has been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 9.1.
  • Change versus previous month

    Short interest in RadNet has recently decreased by 2.07%, indicating that investor sentiment is improving.
  • Dividend Yield

    RadNet does not currently pay a dividend.

  • Dividend Growth

    RadNet does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.35% of the float of RadNet has been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 9.1.
  • Change versus previous month

    Short interest in RadNet has recently decreased by 2.07%, indicating that investor sentiment is improving.
  • News Sentiment

    RadNet has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for RadNet this week, compared to 7 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,613,220.00 in company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of RadNet is held by insiders.

  • Percentage Held by Institutions

    77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about RadNet's insider trading history.
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

RDNT Stock Analysis - Frequently Asked Questions

RadNet's stock was trading at $69.84 at the start of the year. Since then, RDNT shares have decreased by 20.9% and is now trading at $55.26.

RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings data on Thursday, February, 27th. The medical research company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.01. The medical research company earned $477.10 million during the quarter, compared to analysts' expectations of $459.42 million. RadNet had a positive trailing twelve-month return on equity of 1.41% and a negative net margin of 1.73%.
Read the conference call transcript
.

Top institutional shareholders of RadNet include Parallel Advisors LLC. Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, Ranjan Jayanathan, David L Swartz, Lawrence L Levitt, Mark Stolper, David Jeffrey Katz, Cornelis Wesdorp, Michael N Murdock, Christine Nayoma Gordon and Gregory E Spurlock.
View institutional ownership trends
.

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
2/27/2025
Today
7/07/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:RDNT
Employees
11,021
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$69.60
High Stock Price Target
$80.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+26.0%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
98.68
P/E Growth
N/A
Net Income
$2.79 million
Pretax Margin
0.44%

Debt

Sales & Book Value

Annual Sales
$1.83 billion
Cash Flow
$3.42 per share
Price / Cash Flow
16.14
Book Value
$15.31 per share
Price / Book
3.61

Miscellaneous

Free Float
70,828,000
Market Cap
$4.15 billion
Optionable
Optionable
Beta
1.41

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:RDNT) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners